Cargando…

Hemoptysis from the perspective of people with cystic fibrosis

INTRODUCTION: People with cystic fibrosis (CF) are living longer, thus complications associated with age, such as hemoptysis, are increasing. The Institute of Medicine has emphasized the importance of patient‐centeredness. Although guidelines about hemoptysis in people with CF are available, these f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romàn, Christina M., Loughlin, Holly C., Aliaj, Enid, Fay, Robert J., Tran, Quynh T., Borowitz, Drucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064971/ https://www.ncbi.nlm.nih.gov/pubmed/31821725 http://dx.doi.org/10.1111/crj.13132

Ejemplares similares

Virtual Peer Support for People With Cystic Fibrosis and Their Family Members: A Program Evaluation
por: Jeffrey, Aimee, et al.
Publicado: (2021)

Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?
por: Borowitz, Drucy, et al.
Publicado: (2022)

Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis()
por: Smith, Beth A., et al.
Publicado: (2021)

Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
por: Goetz, Danielle Marie, et al.
Publicado: (2021)

Bronchial artery diameter in massive hemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2022)

Creating a Virtual Environment to Enable Two-Way Learning about the Relevance of Clinical Research
por: Borowitz, Drucy, et al.
Publicado: (2020)

Clinical outcomes of cystic fibrosis patients with hemoptysis treated with bronchial artery embolization
por: da Silveira, Marília Amaral Peixoto, et al.
Publicado: (2021)

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation
por: Sawicki, Gregory S., et al.
Publicado: (2022)

Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation
por: Gelfond, Daniel, et al.
Publicado: (2017)

Intestinal Dysbiosis in Young Cystic Fibrosis Rabbits
por: Liang, Xiubin, et al.
Publicado: (2021)

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers
por: Hudock, K., et al.
Publicado: (2022)

Recurrent massive hemoptysis in a patient with cystic fibrosis: balloon assisted Onyx embolization after bronchial artery coil recanalization
por: Mattay, Raghav R., et al.
Publicado: (2021)

An Increase in Chromogranin A-Positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis
por: Cory, Megan, et al.
Publicado: (2018)

Unilateral temporary diaphragmatic paralysis secondary to bronchial artery embolization in a girl with cystic fibrosis and massive hemoptysis: a case report
por: Terlizzi, V., et al.
Publicado: (2020)

Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population
por: Al‐Din, Yasmin, et al.
Publicado: (2023)

In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients
por: Dassner, Aimee M., et al.
Publicado: (2016)

Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018)

Modified forced expiration technique using expiratory resistance in adults with cystic fibrosis
por: Watson, Kathryn, et al.
Publicado: (2023)

OYSTER CILIARY INHIBITION BY CYSTIC FIBROSIS CULTURE MEDIUM
por: Danes, B. Shannon, et al.
Publicado: (1972)

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates
por: Forrester, Jeanne B, et al.
Publicado: (2018)

Evaluation of Home Medication Reconciliation by Clinical Pharmacists for Adult and Pediatric Cystic Fibrosis Patients
por: Louie, Jessica M., et al.
Publicado: (2018)

Transcatheter coil embolization of a complex pulmonary artery pseudoaneurysm with thyrocervical trunk-pulmonary arterial fistulization in a patient with cystic fibrosis and massive hemoptysis
por: Smith, Zachary T., et al.
Publicado: (2022)

Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus
por: Boussaud, Véronique, et al.
Publicado: (2003)

CHARACTERIZATION OF CYSTIC FIBROSIS FACTOR AND ITS INTERACTION WITH HUMAN IMMUNOGLOBULIN
por: Danes, B. Shannon, et al.
Publicado: (1973)

Respiratory Syncytial Virus Infection Disrupts Monolayer Integrity and Function in Cystic Fibrosis Airway Cells
por: Michele, Kong, et al.
Publicado: (2013)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Phenotypic Stability of Staphylococcus aureus Small Colony Variants (SCV) Isolates from Cystic Fibrosis (CF) Patients
por: Kittinger, Clemens, et al.
Publicado: (2019)

Genetic similarity of Burkholderia cenocepacia from cystic fibrosis patients
por: Pretto, Luana, et al.
Publicado: (2013)

Hemoptysis, a developing world perspective
por: Ashraf, Omer
Publicado: (2006)

Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis
por: Freedman, Steven D., et al.
Publicado: (2023)

The impact of COVID‐19 upon the delivery of exercise services within cystic fibrosis clinics in the United Kingdom
por: Tomlinson, Owen W., et al.
Publicado: (2022)

Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against Pseudomonas aeruginosa from cystic fibrosis patients
por: Sader, Helio S, et al.
Publicado: (2021)

Improving imputation in disease-relevant regions: lessons from cystic fibrosis
por: Panjwani, Naim, et al.
Publicado: (2018)

Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients
por: Fanous, Hani K., et al.
Publicado: (2018)

Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa
por: Riveiro, Vanessa, et al.
Publicado: (2022)

Oral Glucose Tolerance Testing Using Candy: A Sweet Solution to Improve Screening in Children with Cystic Fibrosis?
por: Weeks, Caroline, et al.
Publicado: (2023)

Novel approaches to the patient with massive hemoptysis
por: Parrish, Scott, et al.
Publicado: (2012)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Survival of people with cystic fibrosis in Australia
por: Ruseckaite, Rasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_00dad80i4i8eia4gt8c0k3f0kc